To the best of our knowledge, our study is the first to show that—although high levels of IL-8 at baseline correlate with decreased survival in these patients—IL-8 was not increased in all CTEPH patients analyzed at baseline. Here, CXCL8 is linked to chronic thromboembolic pulmonary hypertension.